Cita APA (7a ed.)
Dolled-Filhart, M., Roach, C., Toland, G., Stanforth, D., Jansson, M., Lubiniecki, G. M., . . . Emancipator, K. (2016). Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1. Archives of Pathology & Laboratory Medicine, 140(11), 1243-1250.
Cita Chicago Style (17a ed.)
Dolled-Filhart, Marisa, Charlotte Roach, Grant Toland, Dave Stanforth, Malinka Jansson, Gregory M. Lubiniecki, Gary Ponto, y Kenneth Emancipator. "Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1." Archives of Pathology & Laboratory Medicine 140, no. 11 (2016): 1243-1250.
Cita MLA (9a ed.)
Dolled-Filhart, Marisa, et al. "Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1." Archives of Pathology & Laboratory Medicine, vol. 140, no. 11, 2016, pp. 1243-1250.
Precaución: Estas citas no son 100% exactas.